Publication | Closed Access

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

Breast OncologyOncologyMedicinePhase IiiCapecitabine Versus CapecitabinePathologyBreast CancerCancer TreatmentUpdated EfficacyPharmacologyRadiation Oncology